文献速递艾滋病与性传播感染

基于替诺福韦的抗逆转录病毒治疗下HIV孕妇的血脂与血糖谱

Lipid and Glucose Profiles in Pregnant Women With HIV on Tenofovir-based Antiretroviral Therapy.
PubMed 文献 · Clin Infect Dis · 2025-01-01

基于IMPAACT 2010/VESTED试验数据,分析津巴布韦和乌干达219名孕妇随机启动TAF/FTC+DTG或TDF/FTC+DTG后8周的非空腹代谢指标。结果显示TAF/FTC+DTG组总胆固醇、LDL-C、甘油三酯和脂蛋白(a)均高于TDF/FTC+DTG组,HDL-C较低,但血脂水平在正常参考范围内。

要点

  • 随机启动TAF/FTC+DTG的孕妇8周时总胆固醇较TDF/FTC+DTG组平均高12 mg/dL(95%CI 3.8, 21.1)。
  • TAF/FTC+DTG组LDL-C、甘油三酯和脂蛋白(a)均高于TDF/FTC+DTG组,HDL-C较低。
  • 尽管TAF组血脂较高,但血脂水平仍在正常参考范围内。

核心结论

  • 随机启动TAF/FTC+DTG的孕妇在ART开始后8周内血脂高于随机启动TDF/FTC+DTG者,但血脂水平在正常参考范围内。

研究设计与样本

  • 基于IMPAACT 2010/VESTED试验数据,分析津巴布韦和乌干达随机分配至TAF/FTC+DTG(n=109)或TDF/FTC+DTG(n=110)的219名HIV孕妇。
  • 采集入组后8周样本,测量非空腹血浆葡萄糖、总胆固醇、LDL-C、HDL-C、脂蛋白(a)和甘油三酯,采用线性回归模型估计组间平均差异。

主要发现

  • 入组时平均孕龄22.6周,HIV-1 RNA中位数711 copies/mL,平均年龄25.8岁。
  • 8周时TAF/FTC+DTG组较TDF/FTC+DTG组平均总胆固醇高12 mg/dL(95%CI 3.8, 21.1)。
  • TAF/FTC+DTG组较TDF/FTC+DTG组平均LDL-C高7.1 mg/dL(95%CI 0.2, 14.0)。
  • TAF/FTC+DTG组较TDF/FTC+DTG组平均甘油三酯高12.3 mg/dL(95%CI 1.8, 22.7)。
  • TAF/FTC+DTG组较TDF/FTC+DTG组平均脂蛋白(a)高7.3 mg/dL(95%CI 1.1, 13.6),平均HDL-C低2.8 mg/dL(95%CI 0.1, 5.6)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tenofovir alafenamide (TAF)-based antiretroviral therapy (ART) regimens have been associated with adverse changes in lipid and glucose profiles compared with tenofovir disoproxil fumarate (TDF)-based ART, but data in pregnancy are limited. We evaluated metabolic markers in pregnant women with human immunodeficiency virus (HIV) after starting TAF- versus TDF-based ART. METHODS: We analyzed data within the IMPAACT 2010/VESTED trial, which demonstrated better pregnancy outcomes in pregnant women randomized to initiate TAF/Emtricitabine/Dolutegravir (TAF/FTC + DTG; n = 217) or TDF/FTC + DTG (n = 215). We measured non-fasting plasma concentrations of glucose, total-cholesterol, low-density lipoprotein-cholesterol (LDL-C), high-density lipoprotein-cholesterol (HDL-C), lipoprotein (a), and triglycerides from samples collected 8 weeks after enrollment. We employed linear regression models to estimate by-arm mean differences. RESULTS: In total, 219 participants enrolled in the DTG arms in Zimbabwe and Uganda: 109 in the TAF/FTC + DTG and 110 in the TDF/FTC + DTG arms. At study entry, mean gestational age was 22.6 weeks, median HIV-1 RNA was 711 copies/mL, and mean age was 25.8 years. By 8 weeks, mean total cholesterol was 12 mg/dL higher in women randomized to TAF/ FTC + DTG versus TDF/FTC + DTG (95% confidence interval [CI]: 3.8, 21.1). Pregnant women in the TAF/FTC + DTG arm had higher mean LDL-C (7.1 mg/dL, 95% CI: .2, 14.0), triglycerides (12.3 mg/dL, 95% CI: 1.8, 22.7), lipoprotein (a) (7.3 mg/dL, 95% CI: 1.1, 13.6), and lower mean HDL-C (2.8 mg/dL, 95% CI: .1, 5.6) compared to the TDF/FTC + DTG arm. CONCLUSIONS: Pregnant women randomized to start TAF/FTC + DTG had higher lipids than those randomized to TDF/FTC + DTG within 8 weeks of ART initiation. However, lipid levels were within normal reference ranges.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Eke AC, Brummel SS, Aliyu MH, et al. Lipid and Glucose Profiles in Pregnant Women With HIV on Tenofovir-based Antiretroviral Therapy. Clin Infect Dis. 2025. PMID: 39219495. doi:10.1093/cid/ciae441

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。